000282596 001__ 282596
000282596 005__ 20251210090722.0
000282596 0247_ $$2doi$$a10.1093/braincomms/fcaf464
000282596 0247_ $$2pmid$$apmid:41357353
000282596 0247_ $$2pmc$$apmc:PMC12679710
000282596 037__ $$aDZNE-2025-01354
000282596 041__ $$aEnglish
000282596 082__ $$a610
000282596 1001_ $$00000-0001-7977-1083$$aSchroeter, Matthias L$$b0
000282596 245__ $$aRetinal nerve fibre layer thickness is associated with attention and predicts risk states of dementia.
000282596 260__ $$a[Oxford]$$bOxford University Press$$c2025
000282596 3367_ $$2DRIVER$$aarticle
000282596 3367_ $$2DataCite$$aOutput Types/Journal article
000282596 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1765353918_2464
000282596 3367_ $$2BibTeX$$aARTICLE
000282596 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000282596 3367_ $$00$$2EndNote$$aJournal Article
000282596 520__ $$aAlzheimer's disease is associated with lower circumpapillary retinal nerve fibre layer thickness (cpRNFLT). It remains unclear if dementia risk states, i.e. mild cognitive impairment (MCI) and mild neurocognitive disorder (NCD) might associate with cpRNFLT and whether specific domains of cognitive function are related. The present study compared systematically all cognitive domains as defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) with pointwise analyses of the cpRNFLT and whether cpRNFLT variation can predict MCI and mild NCD. Spectral domain optical coherence tomography scans (768 A-scans of cpRNFLT) were analysed from 1300 participants with reliable measurements, without eye diseases, and further exclusion due to brain disorders. The study was conducted in the framework of the population-based Leipzig Research Centre for Civilization Diseases-(LIFE)-Adult study. The six DSM-5 domains were operationalized by means of both (sub-)scales of the 'Consortium to Establish a Registry for Alzheimer Disease' (CERAD-Plus) neuropsychological test battery and the 'Reading the Mind in the Eyes' test. Age, sex, education and scanning radius were used as additional regressors to adjust for demographics and eye anatomy. 2133 eyes of 1300 subjects were selected (age range 60-79 years). After adjustment for multiple comparisons, in the domain 'attention', worse performance was related to significantly thinner cpRNFL, especially in male participants, most pronounced for temporal and nasal-superior locations. For the domain 'executive function' significantly thicker cpRNFL was found nasally in female participants. There were no significant (P < 0.05) cpRNFLT locations for the DSM-5 domains 'learning/memory', 'perceptual-motor abilities', 'language' and 'social cognition'. Subjects with MCI had thinner cpRNFL temporal-superior compared to subjects with normal cognition. Furthermore, alterations of cpRNFLT in MCI and mild NCD, and subgroups amnestic MCI and amnestic mild NCD existed, for the latter mainly in temporal regions. Compared to cognitively unimpaired, analyses revealed hippocampal volume decreases in MCI and mild NCD groups, and comparable white matter lesion volume, compatible with Alzheimer aetiology. cpRNFL fibre thinning was most prominently associated with lower performance in the attention domain. Highly location specific thinning involved predominantly retinal locations superior and temporal to the optic disc. Thinning in temporal-superior segment was associated with MCI. Temporal thinning indicated amnestic MCI and amnestic mild NCD. Executive function, MCI, and mild NCD presented a concordantly negative association of cognition and RNFLT nasally. As cpRNFLT is obtained conveniently within seconds, our results might assist clinicians by earlier identification of patients at risk for developing cognitive decline associated with diseases like Alzheimer's disease.
000282596 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000282596 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000282596 650_7 $$2Other$$aMRI
000282596 650_7 $$2Other$$ahippocampus
000282596 650_7 $$2Other$$amild cognitive impairment
000282596 650_7 $$2Other$$aneurocognitive disorder
000282596 650_7 $$2Other$$aretinal nerve fibre layer thickness
000282596 7001_ $$00000-0002-9564-1358$$aGirbardt, Johanna$$b1
000282596 7001_ $$aLuck, Tobias$$b2
000282596 7001_ $$0P:(DE-2719)9000725$$aRodriguez, Francisca S$$b3
000282596 7001_ $$aPlant, Gordon T$$b4
000282596 7001_ $$aWicklein, Barbara$$b5
000282596 7001_ $$aWirkner, Kerstin$$b6
000282596 7001_ $$aEngel, Christoph$$b7
000282596 7001_ $$aKynast, Jana$$b8
000282596 7001_ $$aGirbardt, Christian$$b9
000282596 7001_ $$aWang, Mengyu$$b10
000282596 7001_ $$00000-0003-0617-0097$$aPolyakova, Maryna$$b11
000282596 7001_ $$aHinz, Andreas$$b12
000282596 7001_ $$aWitte, A Veronica$$b13
000282596 7001_ $$00000-0001-7117-4268$$aKirsten, Toralf$$b14
000282596 7001_ $$aLoeffler, Markus$$b15
000282596 7001_ $$00000-0003-2604-2404$$aVillringer, Arno$$b16
000282596 7001_ $$aRiedel-Heller, Steffi G$$b17
000282596 7001_ $$aElze, Tobias$$b18
000282596 7001_ $$00000-0003-0183-0340$$aRauscher, Franziska G$$b19
000282596 773__ $$0PERI:(DE-600)3020013-1$$a10.1093/braincomms/fcaf464$$gVol. 7, no. 6, p. fcaf464$$n6$$pfcaf464$$tBrain communications$$v7$$x2632-1297$$y2025
000282596 8564_ $$uhttps://pub.dzne.de/record/282596/files/DZNE-2025-01354.pdf$$yRestricted
000282596 8564_ $$uhttps://pub.dzne.de/record/282596/files/DZNE-2025-01354.pdf?subformat=pdfa$$xpdfa$$yRestricted
000282596 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000725$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000282596 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000282596 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBRAIN COMMUN : 2022$$d2024-12-20
000282596 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-20
000282596 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-20
000282596 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-03T10:36:45Z
000282596 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-03T10:36:45Z
000282596 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-03T10:36:45Z
000282596 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2024-04-03T10:36:45Z
000282596 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-20
000282596 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-20
000282596 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-20
000282596 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-20
000282596 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-20
000282596 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-20
000282596 9201_ $$0I:(DE-2719)1510900$$kAG Rodriguez$$lPsychosocial Epidemiology and Public Health$$x0
000282596 980__ $$ajournal
000282596 980__ $$aEDITORS
000282596 980__ $$aVDBINPRINT
000282596 980__ $$aI:(DE-2719)1510900
000282596 980__ $$aUNRESTRICTED